
|Articles|April 1, 2002
MF remains diagnosis, treatment challenge
New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














